Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07492706
What this trial is testing

Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women

Who this might be right for
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company 120
Testing effectiveness (Phase 2)Study completedNCT01014806
What this trial is testing

Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

Who this might be right for
Influenza
Novavax 467
Early research (Phase 1)Study completedNCT01459198
What this trial is testing

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00119873
What this trial is testing

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00697866
What this trial is testing

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

Who this might be right for
Hepatitis B
GlaxoSmithKline 951
Large-scale testing (Phase 3)Study completedNCT01162122
What this trial is testing

Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects

Who this might be right for
Influenza
Novartis Vaccines 7,109
Early research (Phase 1)Active Not RecruitingNCT06442241
What this trial is testing

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)RSV Infection
Guangzhou Patronus Biotech Co., Ltd. 84
Early research (Phase 1)Looking for participantsNCT07317154
What this trial is testing

Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients

Who this might be right for
Recurrent Respiratory Papillomatosis
Mayo Clinic 9
Early research (Phase 1)Study completedNCT03008122
What this trial is testing

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area

Who this might be right for
Zika Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 91
Early research (Phase 1)Study completedNCT01511419
What this trial is testing

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Who this might be right for
InfluenzaAvian Influenza
PATH 40
Early research (Phase 1)Study completedNCT00387569
What this trial is testing

Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 99
Large-scale testing (Phase 3)Study completedNCT00848029
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Who this might be right for
Pre-pandemic Influenza Vaccine
Novartis Vaccines 240
Large-scale testing (Phase 3)Study completedNCT05546502
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

Who this might be right for
Vaccine ReactionVaccine Adverse Reaction
PT Bio Farma 1,050
Not applicableStudy completedNCT01264601
What this trial is testing

Safe Administration of Flu Vaccine to Egg Allergic Children

Who this might be right for
Egg Allergy
University of Michigan 31
Testing effectiveness (Phase 2)Study completedNCT05004181
What this trial is testing

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Who this might be right for
SARS-CoV-2 InfectionCOVID-19SARS-CoV-2 Acute Respiratory Disease+1 more
BioNTech SE 1,380
Early research (Phase 1)Study completedNCT01094873
What this trial is testing

Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

Who this might be right for
Hepatitis C
ReiThera Srl 35
Not applicableStudy completedNCT03931239
What this trial is testing

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Vabiotech 222
Large-scale testing (Phase 3)Study completedNCT01911754
What this trial is testing

Japanese Pediatric H5N1 Vaccine Study

Who this might be right for
Influenza
Alachua Government Services, Inc. 60
Early research (Phase 1)Study completedNCT00261001
What this trial is testing

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

Who this might be right for
Healthy VolunteersHIV Infection
Objectif Recherche Vaccins SIDA 38
Testing effectiveness (Phase 2)Study completedNCT00349141
What this trial is testing

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 270
Next Page